Detection of T(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization

Blood

Volumn 94, Issue 2, 1999, Pages 724-732

  Finelli, Palma ^a   Fabris, Sonia ^a   Zagano, Savina ^a   Baldini, Luca ^a   Intini, Daniela ^a   Nobili, Lucia ^a   Lombardi, Luigia ^a   Maiolo, Anna Teresa ^a   Neri, Antonino ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INTERPHASE; MALE; MULTIPLE MYELOMA; ONCOGENE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0033566346     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.724.414k05_724_732     Document Type: Article

References (38)

1. Gaidano G, Dalla-Favera R: Molecular biology of lymphomas, in De Vita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, PA, Lippincott-Raven, 1997, p 2131
2. Barlorgie B: Multiple Myeloma. Hematology/Oncology Clinics of North America, vol 11. Philadelphia, PA, Saunders, 1997
3. Hallek M, Bergsagel PL, Anderson KC: Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 91:3, 1998
4. Heim S, Mitelman F: Cancer Cytogenetics. New York, NY, Wiley-Liss, 1995
5. Dewald GW, Jenkins RB: Cytogenetic studies of patients with monoclonal gammopathies, in Wiernik PH, Canellos GP, Dutcher JP, Kyle RA (eds): Neoplastic Diseases of the Blood. New York, NY, Churchill Livingstone, 1996, p 515
6. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraille A, Carrasco JL, Solé F, Cuesta B, Gullon A: Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations. Genes Chromosom Cancer 18:84, 1997
7. Fielder W, Weh HJ, Hossfeld DK: Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma. Br J Haematol 81:58, 1992
8. Raynaud SD, Bekri S, Leroux D, Grosgeorge J, Klein B, Bastard C, Gaudray P, Simon M-P: Expanded range of 11 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes Chromosom Cancer 8:80, 1993
9. Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM: Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88:674, 1986
10. Taniwaki M, Nishida K, Takashima T, Nakagawa H, Fuji H, Tamaki T, Shimazaki C, Horiike S, Misawa S, Abe T, Kashima K: Nonrandom chromosomal rearrangements of the 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood 84:2283, 1994
11. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM: Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931, 1996
12. Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M: The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 90:526, 1997
13. Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, Marzella R, Rocchi M, Otsuki T, Lombardi L, Maiolo AT, Neri A: A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood 90:4062, 1997
14. Chesi M, Nardini E, Brents LA, Schroch E, Ried T, Kuehl WM, Bergsagel PL: Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260, 1997
15. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RSK, Dalla-Favera R: Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 17:226, 1997
16. Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schrock E, Ried T, Kuehl MW: Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 91:4457, 1998
17. Thompson LM, Plummer S, Schalling M, Altherr MR, Gusella JF, Housman DE, Wasmuth JJ: A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4. Genomics 11:1133, 1991
18. Stec I, Wright TJ, van Ommen GB, de Boer PAJ, van Haeringer A, Moorman AFM, Altherr MR, den Dunnen JT: WHSCI, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet 7:1071, 1998
19. Chesi M, Nardini E, Lim RSC, Smith KD, Kuehl MW, Bergsagel PL: The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 92:3025, 1998
20. Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, Rothermundt C, Gsur A, Jager U, Heinz R, Lechner K, Ludwig H, Huber H: Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res 55:3854, 1995
21. Drach J, Angerler J, Schuster J, Rothermundt C, Thalhammer R, Haas OA, Jager U, Fiegl M, Geissler K, Ludwig H, Huber H: Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 86:3915, 1995
22. Durie BGM, Salmon S: A clinical staging system for multiple myeloma. Cancer 36:842, 1975
23. Lichter P, Tang Chang C-J, Call K, Hermanson G, Evans GA, Housman D, Ward DC: High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64, 1990
24. Baxendale S, MacDonald ME, Mott R, Francis F, Lin C, James M, Zehetner G, Hummerich H, Valdes J, Collins FS, Deaven LJ, Gusella JF, Lehrach H, Bates GP: A cosmid conting and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene. Nat Genet 4:181, 1993
25. Laffan M, Luzzatto L: Anomalous rearrangements of the immunoglobulin heavy chain genes in human leukemias support the loop-out mechanism of class switch. J Clin Invest 90:2299, 1992
26. Dewald GW, Schad CR, Christensen, Tiede AL, Zinsmeister AR, Spurbeck JL, Thibodeau SN, Jalal SM: The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genet Cytogenet 71:7, 1993
27. Smith L, Balorgie B, Alexanian R: Biclonal and hypodiploid multiple myeloma. Am J Med 80:841, 1986
28. Avet-Loiseau H, Li JY, Facon T, Brigaudeau C, Maloisel F, Talmant P, Lai JL, Rapp MJ, Praloran V, Harousseau JL, Bataille R: The 14q32 region is frequently involved in chromosomal translocations in multiple myeloma, especially with the 4p16 and 11q13 region. Br J Haematol 102:9, 1998 (abstr)
29. Cigudosa JC, Rao PH, Calasanz MJ, Odero MD, Michaeli J, Jhanwar SC, Chaganti RSK: Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood 91:3007, 1988
30. Taniwaki M, Nishida K, Ueda Y, Misawa S, Nagai M, Tagawa S, Yamagami T, Sugiyama H, Abe M, Fukuhara S, Kashima K: Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization. Blood 85:3223, 1995
31. Ronchetti D, Finelli P, Richelda R, Baldini L, Rocchi M, Viggiano L, Cuneo A, Bogni S, Fabris S, Lombardi L, Maiolo AT, Neri A: Molecular analysis of 11q13 breakpoints in multiple myeloma. Blood 93:1330, 1999
32. Weh HJ, Fiedler W, Hossfeld DK: Cytogenetics in multiple myeloma: Are we studying the "right" cells?. Eur J Haematol 45:236, 1990
33. Johnson DE, Williams LT: Structural and functional diversity in the fgf receptor multigene family. Adv Cancer Res 60:1, 1993
34. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115, 1992
35. Muenke M, Schell U: Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 11:308, 1995
36. Webster MK, Donoghue DJ: FGFR activation in skeletal disorders: Too much of a good thing. Trends Genet 13:178, 1997
37. Fracchiolla NS, Luminari S, Baldini L, Lombardi L, Maiolo AT, Neri A: FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma (letter). Blood 92:2987, 1998
38. Madisen L, Groudine M: Identification of a locus control region in the immunoglobulin heavy-chain locus that regulates c-myc expression in plasmacytoma and Burkitt's lymphoma cell. Genes Dev 8:2212, 1994 ss